Autologous Bone Marrow Mesenchymal Stem Cells therapy (Zhujiang Hospital)

N/A

Report date: 2023/05/10 20:00:50

Base Information

Drug NameAutologous Bone Marrow Mesenchymal Stem Cells therapy (Zhujiang Hospital)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapyCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionT lymphocyte replacements
TargetsNot applicable
Therapy Area/IndicationsIschemic Stroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesSouthern Medical University Zhujing Hospital
China Registration ClassN/A

Develop Information

Active CompaniesZhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, China
Inactive CompaniesN/A
Active IndicationsIschemic Stroke
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A